Sumana Chakravarty,Stephen L. Hoffman,Moriya Tsuji
申请号：
US15046575
公开号：
US09642909B2
申请日:
2016.02.18
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed herein are pharmaceutical compositions comprising Plasmodium sporozoite-stage parasites and compatible glycolipid adjuvants useful in vaccines for preventing or reducing the risk of malaria. In particular, human host range Plasmodium and analogues of α-galactosylceramide (α-GalCer), a ligand for natural killer T (NKT) cells, are combined in pharmaceutical compositions, which are useful as vaccines against malaria. Methods of use are also provided.
